(NASDAQ:BNGO), SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, November 13, 2025, at 4:30 p.m. Eastern Time to report financial results for the third quarter 2025 and to highlight recent corporate progress. Conference Call & Webcast […]
Hub Group Reports Third Quarter 2025 Results GlobeNewswire October 30, 2025 Highlights: GAAP diluted earnings per share (EPS) of $0.47 for the third quarter Third quarter revenue of $934 million Non-GAAP adjusted EPS of $0.49, which excludes adjusted items in the quarter Operating income of $39 million or 4.2% of revenue, adjusted operating income (non-GAAP)
(NASDAQ:ZSPC), SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — zSpace (Nasdaq: ZSPC) (“zSpace” or the “Company”), a global leader in immersive augmented reality (AR) learning solutions for education, announced today that it plans to release financial results for the third quarter ended September 30, 2025, on Thursday, November 13, 2025, after the close of
(NASDAQ:SNYR), WESTBROOK, Maine, Oct. 30, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that it plans to release financial results for the third quarter ended September 30, 2025, on Thursday, November 13, 2025, before the open of market trading. In conjunction
(NasdaqGM:ISPO), DENVER, Oct. 30, 2025 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today announced plans to release financial and operating results for the quarter ended September 30, 2025, after market close on Tuesday, November 4, 2025. The Company will host a conference
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 GlobeNewswire October 30, 2025 CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2025
Legence Announces Extension and Repricing of Term Loan along with Increase and Extension of Revolving Credit Facility GlobeNewswire October 30, 2025 SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced the amendment of its $798 million Term Loan Credit Facility, extending the maturity date by
LogicMark, Inc. to Announce Third Quarter 2025 Financial Results on November 12, 2025 GlobeNewswire October 30, 2025 LOUISVILLE, Ky., Oct. 30, 2025 (GLOBE NEWSWIRE) — LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, will release its financial results for the
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update Company to Host Conference Call Today, October 30, at 4:30pm ET GlobeNewswire October 30, 2025 BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness
iRhythm Technologies Announces Third Quarter 2025 Financial Results GlobeNewswire October 30, 2025 SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2025. Third